Series I - EndoGastric Solutions
Investment Firm
Overview
EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.
Announced Date
Jun 19, 2018
Funding Type
Series I
Highlights
Location
United States, North America
Social
Participant Investors
7
Round Details and Background
EndoGastric Solutions raised $40648790 on 2018-06-19 in Series I
EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.
Company Funding History
22
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 04, 2003 |  Series A - EndoGastric Solutions | 2 | - | 5.0M |
| Sep 11, 2004 | Series B - EndoGastric Solutions | 3 | - | 12.0M |
| Jul 08, 2009 | Venture Round - EndoGastric Solutions | - | 7.5M | |
| Jun 30, 2009 | Venture Round - EndoGastric Solutions | 5 | - | 3.8M |
Recent Activity
There is no recent news or activity for this profile.